Milestone
Portfolio company GEn1E Lifesciences received FDA Orphan Drug and Rare Pediatric Disease designations for its Duchenne muscular dystrophy therapy.
GEn1E
JUN 9, 2026
Every public signal F4 has attached to this firm, with sources and cross-entity links.
GEn1E
MEXT
Tina Cho joined as Associate
Vori
Frore Systems
Frore Systems CES Innovation Award 2026
Cynch AI
Chipstack
Avicena Tech
Arrcus
Avicena Tech
Arrcus
Acante
Swift Navigation